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Abstract 
Background: The disposable bronchoscope is an excellent alternative to face the problem of SARS-CoV-2 and other 
cross infections, but the bronchoscopist’s perception of its quality has not been evaluated.
Methods: To evaluate the quality of the Ambu-aScope4 disposable bronchoscope, we carried out a cross-sectional 
study in 21 Spanish pulmonology services. We use a standardized questionnaire completed by the bronchoscopists at 
the end of each bronchoscopy. The variables were described with absolute and relative frequencies, measures of cen-
tral tendency and dispersion depending on their nature. The existence of learning curves was evaluated by CUSUM 
analysis.
Results: The most frequent indications in 300 included bronchoscopies was bronchial aspiration in 69.3% and the 
median duration of these was 9.1 min. The route of entry was nasal in 47.2% and oral in 34.1%. The average score for 
ease of use, image, and aspiration quality was 80/100. All the planned techniques were performed in 94.9% and the 
bronchoscopist was satisfied in 96.6% of the bronchoscopies. They highlighted the portability and immediacy of the 
aScope4TM to start the procedure in 99.3%, the possibility of taking and storing images in 99.3%. The CUSUM analysis 
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Background
Fiberoptic bronchoscopy is a widely used procedure 
in most hospitals around the world, especially for the 
diagnosis of infectious, inflammatory and tumor lung 
diseases. It is estimated that 92,000 bronchoscopies are 
performed annually in Spain, with a tendency to growth. 
Unfortunately, bronchoscopy can spread infections by 
spreading an infection in the same patient, by cross-
infection between patients, or by infecting the personnel 
involved in the procedure [1].
The effects of cross infection can be severe for the 
patient and the health system and include complications 
of the infection and its consequences in terms of labora-
tory tests, medications, hospital stay, disability, and direct 
and indirect costs. For this reason, it is necessary to 
take extreme care and precautions in the decontamina-
tion and cleaning of equipment [2]. Despite complex and 
advanced endoscope cleaning and disinfection systems, 
disinfection is often inadequate [3–5], with the conse-
quent risk of cross infection [5–7].
A disposable bronchoscope could decrease the risk of 
cross infection and increase accessibility to bronchoscopy 
in centers of less complexity or with limited resources 
and has been recommended by most respiratory societies 
for bronchoscopies during the SARS-COv-2 pandemic 
[8–11]. Patients on mechanical ventilation [12], immu-
nosuppressed or with infectious contagious diseases are 
those with the highest risk for cross infections and where 
these devices may have a more relevant role. These bron-
choscopes are also desirable for procedures with a high 
risk of damage the bronchoscope (e.g. bronchoscopy by 
orotracheal tube), to reduce repair costs [13].
The utility of single-use bronchoscopes has been exten-
sively studied in anesthesiology, where they have been 
compared with reusable bronchoscopes in terms of ease 
of use [14]. In the field of pulmonology, there are not 
publications listing the perception of pulmonologists 
when using these bronchoscopes for conventional diag-
nostic and therapeutic techniques.
This study seeks to evaluate the perception of the bron-
choscopist about the quality of the  Ambu® aScope4™ 
bronchoscope and the existence of a learning curve dur-
ing the performance of conventional bronchoscopies of 
low complexity in the usual practice in pulmonology ser-
vices of university hospitals of third level of care.
Methods
Design
A prospective, observational, multicenter, cross-sectional 
study was conducted of an approved disposable broncho-
scope  (Ambu® aScope4™) with European certification 
(CEA) and used according to the product data sheet.
The study was carried out between February and 
August 2018, in tertiary care university hospitals with 
experience in performing bronchoscopies. The study 
was approved by the ethics committees of each institu-
tion and all the participants signed the informed con-
sent both for their participation in the study and for the 
bronchoscopy.
The inclusion criteria were patients over 18 years with 
indication for the performance of a diagnostic bronchos-
copy and that the procedure be approved by signing the 
informed consent. Exclusion criteria were bronchos-
copies that required flexible interventional bronchos-
copies or in which highly complex equipment was to 
be used. 300 subjects were recruited prospectively and 
consecutively in 21 Spanish pulmonology services. 
Bronchoscopists had an experience of more than 500 
bronchoscopies.
There is few published experience with this broncho-
scope for complex techniques, thus cases with risk of 
bleeding were excluded from the study. The bronchosco-
pies were only diagnostic bronchoscopies with bronchial 
aspiration and bronchoalveolar lavage (BAL) and thera-
peutic bronchoscopies that involved the aspiration of 
secretions or hematic remains.
The procedures were performed following the same 
sedation and analgesia protocol as in bronchoscopies 
with the conventional videobronchoscope: local anesthe-
sia on the airway with 1% lidocaine. On the other hand, 
conscious sedation with propofol, fentanyl or midazolam 
was used at the discretion of each research center who 
participates in the study. The bronchial aspirate (BAS) 
consisted of collecting the secretions found during the 
examination by means of simple aspiration or by using 
instillations of small volumes of physiological serum 
showed average scores > 70/100 from the first procedure and from the 9th procedure more than 80% of the scores 
exceeded the 80/100 score.
Conclusions: The aScope4™ scored well for ease of use, imaging, and aspiration. We found a learning curve with 
excellent scores from the 9th procedure. Bronchoscopists highlighted its portability, immediacy of use and the pos-
sibility of taking and storing images.
Keywords: Bronchoscopy, Quality, CUSUM analysis, aScope4™, Bronchoalveolar lavage
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(5–10 cc) to favor the collection or try to carry away cel-
lularity or microbiota. of the airway.
BAL was performed by interlocking in a segmental 
or subsegmental bronchus (depending on the bron-
chial anatomy), three 50-cc aliquots of 0.9% saline were 
instilled and successively aspirated and processed for 
study. It was assumed that the first aliquot would collect 
a sample from the bronchial area, while the last volume 
instilled would carry distal airway and alveolar contents.
The study aims to validate the bronchoscope by means 
of a personal subjective questionnaire carried out by an 
experienced bronchoscopist without considering quanti-
fiable parameters such as the quality of the samples or the 
volume of the BAL recovered.
In the cases included in the study, the bronchoscopy 
was performed by two observers, the main operator who 
operated the bronchoscope and a collaborator who ana-
lyzed the exploration during its development. A video 
of each bronchoscopy was recorded and saved in the 
memory of the  Ambu® aView™ device for later visuali-
zations. The videos were labeled according to the order 
number and date of the examination, without the patient 
data being included. All procedures were anonymous in 
storage and confidentiality and privacy regulations were 
respected.
A search of the literature was carried out on ques-
tionnaires that measured the quality of the fiberoptic 
bronchoscopes for the performance of diagnostic bron-
choscopies and none was found, so a new questionnaire 
was constructed on the Bronchoscope Quality Question-
naire (BQQ) by means of an expert consensus to estab-
lish the relevant items and domains to evaluate in the 
quality of the bronchoscope. A pilot test was carried out 
to adjust the questions and the psychometric measures of 
the final instrument were evaluated.
The BQQ was assessed independently and masked by 
the two bronchoscopists after the bronchoscopy at two 
different times. Both questionnaires were archived and 
after a period of 1–15 days from the bronchoscopy, one 
of the two bronchoscopists viewed the video of the bron-
choscopy, and completed the questionnaire again.
Statistic analysis
The qualitative variables were described with absolute 
and relative frequencies, the quantitative ones by means 
and standard deviations, or medians and interquartile 
range (25th percentile to 75th percentile) depending on 
their distribution. The internal consistency of the ques-
tionnaire was measured with the Cronbach’s alpha coeffi-
cient. To unify the item scores and to be able to compare 
them, the standardized scores were calculated using the 
following equation:
In this way, the standardized score was left with a 
range from 0 (worst possible score) to 100 (best pos-
sible score).
To assess the bronchoscopies quality related to the 
number of procedures performed with the aScope4 and 
the existence of learning curves, we used the binary 
CUSUM analysis method. We describe the details of this 
method in the Additional file  1, which we summarize 
below. We consider an acceptable failure rate (p0) 10% 
(90% of the scores in the evaluated aspect ≥ 80/100) and 
an unacceptable failure rate of 20% (p1) (less than 80% of 
the scores in the evaluated aspect ≥ 80/100); we defined a 
type I error (probability of falsely qualifying the broncho-
scope as inadequate, designated as α) of 0.1 and a type II 
error (probability of falsely qualifying the bronchoscope 
as excellent, designated as β) of 0.1 [15–17]. We plotted 
the CUSUM graph by plotting the index number of each 
case (bronchoscopy) on the x-axis versus the cumulative 
sum score after that case on the y-axis. Consecutive fail-
ures drive the CUSUM curve upward while consecutive 
successes drive the CUSUM curve downward.
The CUSUM chart includes horizontal lines called 
decision limits  (h1 y  h0), which are the limits of an accept-
able or unacceptable error rate. When the CUSUM curve 
crosses a decision boundary from above, it is inferred 
that the failure rates were within the predetermined 
acceptable rate of 10% (excellent performance); when 
the CUSUM curve crosses a decision limit from below, 
it is inferred that failure rates have reached the unac-
ceptable failure rate of 20% (inadequate performance); If 
the CUSUM curve is stable between two decision limits, 
stable performance is inferred within good levels. There-
fore, good performance is assumed when the CUSUM 
curve slopes downward or remains stable, but when the 
curve slopes upward it indicates a lower than acceptable 
success rate. Decision limits (h1 and h0) were calculated 
based on the risk of type I errors (α) and II (β). In our 
case, as α = β = 0,1; p0 = 10% and p1 = 20%; therefore 
 h0 = h1 = 2,71. For this reason, we mark the decision 
limits of our CUSUM charts as horizontal lines start-
ing from the axis and at intervals of 2.71. Software used 
Microsoft Excel 2016 (Microsoft Corporation, Redmond, 
WA, USA) and STATA vs 14.0 (StataCorp, Texas, USA).
Assuming a confidence of 95%, a margin of error of 6% 
and an average proportion of 50%
for the qualitative variables (more demanding scenario 
in terms of sample size), a sample size of 267 bronchos-
copies was deemed necessary for the study, to compen-
sate possible losses it was decided to increase to 300 
bronchoscopies.
score obtained on the item
maximum possible score on the item
× 100.
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Results
A total of 300 bronchoscopies were performed, 15 proce-
dures were made by each Spanish pulmonology services, 
36 bronchoscopist participated with a median of 4 bron-
choscopies (IQR 2.1—8.4). The most frequent indications 
were BAS in 69.3% of all cases (208/300; 95% CI 63.9–
74.3%) and BAL in 125 of all bronchoscopies (41.7%; 
95% CI: 36.2–47.3%) (Table  1 and Additional file  1: Fig. 
S1). The nasal route of entry was used in 47.2% (141/300; 
95% CI 41.6–52.8%) and the oral one in 34.1% of cases 
(95% CI 29.0–39.7%) (Table 1 and Additional file 1: Fig. 
S2). The duration of the bronchoscopy had a median of 
9.1  min (IQR 6.0–13.0) (Table  1). The reliability of the 
questionnaire measured by Cronbach’s alpha was 0.88.
The average in user-friendliness, image and aspiration 
quality was 4 out of a maximum score of 5 (standardized 
score: 80/100; for a maximum score of 100 and a mini-
mum of 0). The average standardized score for ease of 
use, image quality, and aspiration was 80/100 (Table  2 
and Fig. 1). In 6% of the cases it was necessary to change 
the aScope 4, the most frequent reasons were limita-
tion to reach the goals of the procedure and damage to 
the bronchoscope. 54.4% considered that the aScope had 
lower image quality than reusable video endoscopes. In 
more than 90% of the cases, all the pulmonary segments 
could be reached and all the planned techniques could be 
Table 1 General characteristics
95% CI 95% confidence interval, IQR interquartile range
N % 95% CI
Indication for bronchoscopy
 Bronchial lavage or bronchial aspirate 208 69.3 63.9% 74.3%
 Bronchoalveolar lavage 125 41.7 36.2% 47.3%
 Therapeutic aspiration of secretions 30 10.0 7.1% 13.9%
 Bronchial biopsy 17 5.7 3.6% 8.9%
Route of entry for bronchoscopy
 Nasal 141 47.2 41.6% 52.8%
 Oral 102 34.1 29.0% 39.7%
 Orotracheal tube 27 9.0 6.3% 12.8%
 Tracheostomy 26 8.7 5.1% 14.6%
 VMNI mask 1 0.3 0.1% 1.9%
 Other 2 0.7 0.2% 2.4%
Bronchoscopy duration
Time in minutes, median (IQR) 9.1 (6.0–13.0)
Table 2 Quality of the aScope 4 bronchoscope
95% CI 95% confidence interval
a IQR: interquartile range
b Standardized score: calculated by dividing the score obtained by the maximum possible score and multiplying by 100, the best possible standardized score is 100% 
and the worst is 0%
Median IQRa Score 
standardized 
(%)b
Complexity to assemble the device 0: impossible → 5: extremely easy 4.0 4.0–5.0 80
Intubation facility 0: extremely difficult → 10: extremely easy 8.0 8.0–9.0 80
Ease of maneuvering in the tracheobronchial tree 0: extremely difficult → 10: extremely easy 8.0 7.0–9.0 80
Vasculature image quality 0: impossible to see vasculature → 5: maximum sharp-
ness of vasculature
4.0 3.0–4.0 80
Mucous image quality 0: impossible to see mucosa folds → 5: maximum clarity 
of mucosa folds
4.0 3.0–4.0 80
Image quality of subsegmental bronchi from the seg-
mental bronchus
0: impossible to see subsegmental bronchi → 5: maxi-
mum sharpness of subsegmental bronchi
4.0 3.0–4.0 80
Image quality for pathological mucosal alterations 0: impossible visualization of pathological lesions → 5: 
maximum sharpness of pathological lesions
4.0 3.0–4.0 80
Image quality in case of bleeding 0: complete image loss in bleed → 4: highest image 
quality in bleed
3.0 2.0–3.0 75
Global image quality 0: no image → 10: optimal image quality 8.0 7.0–8.0 80
Quality to suction secretions 0: impossible to suction secretions → 5: excellent ability 
to suction secretions
4.0 4.0–4.0 80
Quality to suction blood clots and debris 0: impossible to suction blood clots and debris → 5: 
excellent ability to suction clots and blood debris
4.0 4.0–4.0 80
Capacity to suction blood in active bleeding 0: impossible to suction blood in active bleeding → 5: 
excellent ability to suction blood in active bleeding
4.0 3.0–4.0 80
Global suction quality 0: zero suction capacity → 10: optimal suction capacity 8.0 8.0–9.0 80
Average score for ease of use, image quality and aspiration quality 80
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performed, for a general satisfaction with the device  of 
86.4% and a recommendation for its use in similar cases 
in 86.4% of the cases. times (Table 3).
The analysis by the CUSUM Analysis graphical method 
to detect if there was a learning curve in the use of the 
 Ambu® aScope4™ showed the following learning points 
(point in which the scores exceeded 80/100 in more 80% 
of bronchoscopies): ease of passing the fiberoptic bron-
choscope to the trachea (intubation) in the 3rd proce-
dure, ease of maneuvering during the bronchoscopy in 
the 4th procedure, and image quality during the bron-
choscopy in the 9th procedure (Fig.  2). Before these 
learning points the average scores for these aspects were 
between 70/100 and 80/100. The assembly of the equip-
ment and the quality of aspiration of the bronchoscope 
obtained standardized scores higher than 80/100 from 
the first procedure.
Fig. 1 Image of the proximal third of the trachea obtained 
with aScope 4 of a patient showing an osteochondroplastic 
tracheobroncopathy
Table 3 Capacity of the aScope 4TM bronchoscope to perform the planned techniques
95% CI 95% confidence interval
n % 95% CI
Loss of functionality or deterioration during the procedure No 287 97.0 94.3–98.4%
Yes 9 3.0 1.6–5.7%
Need to change bronchoscope during the procedure It was not necessary to change 283 94.3 91.1–96.4%
Changed due to rupture or damage to the bronchoscope 2 0.7 0.2–2.4%
Changed for bad aspiration 1 0.3 0.1–1.9%
Changed for limitation to reach procedure goals 3 1.0 0.3–2.9%
It was changed for a bad image 1 0.3 0.1–1.9%
It was changed for another reason 10 3.3 1.8–6.0%
Compared to other video-endoscopic equipment how did 
you find the Ambú
Much better quality 9 3.1 1.6–5.7%
More quality 35 11.9 8.7–16.1%
Equal quality 90 30.6 25.6–36.1%
Less quality 152 51.7 46.0–57.4%
Much less quality 8 2.7 1.4–5.3%
Were you able to reach all lung segments? Yes 272 91.9 88.2–94.5%
No 19 6.4 4.1–9.8%
Does not apply 5 1.7 0.7–3.9%
Ability to perform all the techniques provided Yes 280 94.9 91.8–96.9%
No 12 4.1 2.3–7.0%
Does not apply 3 1.0 0.3–2.9%
General satisfaction with the bronchoscope Very satisfied 3. 4 11.6 8.4–15.7%
Satisfied 102 34.7 29.5–40.3%
Neutral 118 40.1 34.7–45.8%
Somewhat unsatisfied 39 13.3 9.9–17.6%
Dissatisfied one 0.3 0.1–1.9%
I would recommend using this bronchoscope for similar 
procedures
I would recommend that it always be used 3. 4 11.6 8.4–15.7%
I would recommend that it be used in most cases 102 34.7 29.5–40.3%
I would recommend that it be used in an acceptable number 
of cases
118 40.1 34.7–45.8%
I would recommend that it be used only in very select cases 39 13.3 9.9–17.6%
I would recommend that it never be used 1 0.3 0.1–1.9%
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The most outstanding characteristics of the bron-
choscope were its portability and immediacy to start 
the procedure in 99.3% (296/300; 95% CI 97.6–99.8%), 
its sterility in 96.3% (287/300; 95% CI 93.5–97.9%), 
the possibility of taking and storing images and videos 
of the procedure in 99.3% of cases (298/300; 95% CI 
97.6–99.8%) and 88.6% (263/297; 95% CI 84.4–91.7%) 
considered that the images and videos were of suf-
ficient quality. 93% of bronchoscopists considered it 
useful that the bronchoscope be disposable and for 
single use (277/300; 95% CI 89.5–95.3%). In one of the 
units of non-invasive mechanical ventilation where 
this study was conducted, highlighted the usefulness of 
the aScope 4 left at the bedside of a patient who pre-
sented dyspnea due to severe accumulation of secre-
tions, by allowing them to aspirate them under direct 
vision more effectively than with the aspiration probe 
at blind.
Discussion
Our study provides as novel aspects the evaluation of 
the bronchoscopist’s perception of the quality of the 
aScope4™ disposable bronchoscope through a standard-
ized questionnaire and the measurement of its learning 
curve. The aScope4™ was very well evaluated in terms of 
ease of use, imaging and aspiration, obtaining an aver-
age score of 80/100 and a high degree of satisfaction in 
the bronchoscopist. After the 9th procedure, the scores 
exceeded 80/100 in more than 80% of the bronchosco-
pies. They highlighted its portability, immediacy to start 
the procedure and the possibility of storing the images.
New bronchoscopes have recently been introduced 
that offer advantages over existing ones. The quality 
assessment of these bronchoscopes should be done in the 
most objective way possible, to validate their function-
ality. The measurement of the bronchoscopist’s percep-
tion using standardized questionnaires that include the 
Fig. 2 Plots of cumulative checksums (CUSUM analysis). Intubation: passing the bronchoscope through the vocal folds into the trachea. When 
the CUSUM curve is directed upward it indicates inadequate performance (less than 80% of procedures were scored with a standardized score 
≥ 80/100), when the curve stabilizes indicates that between 80 and 90% of the procedures were rated with a standardized score ≥ 80/100, when 
the curve is directed downwards indicates that more than 90% of the procedures were scored with a standardized score ≥ 80/100. The assembly of 
the equipment and the quality of aspiration obtained standardized scores ≥ 80/100 from the first procedure. Intubation ease obtained standardized 
scores ≥ 80/100 in more than 80% of cases since the 3rd procedure, the ease of maneuver obtained standardized scores ≥ 80/100 in more than 
80% of cases since the 4th procedure, the image quality obtained standardized scores ≥ 80/100 in more than 80% of cases since the 9th procedure
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most relevant domains is a key element for the valida-
tion of these devices. In the absence of a questionnaire 
with these characteristics, we designed one by a panel of 
expert bronchoscopists, which included questions related 
to the route of entry, ease of assembly of the equipment, 
ease of operation, image quality and aspiration, robust-
ness of the equipment to maintain full functionality and 
to allow the planned sampling, in addition to the degree 
of general satisfaction.
The evaluation of the psychometric properties of the 
BQQ showed a very good internal consistency as meas-
ured by Cronbach’s alpha, with a value of 0.88 [18]. It is 
noteworthy that the Cronbach’s alpha coefficient can 
have values between 0 and 1, 0 indicates absence of con-
sistency and 1 total consistency. Values between 0.8 and 
0.9 are considered very good, values less than 0.7 are con-
sidered low and values greater than 0.94 are considered 
indicative of redundancy in the questions. The participa-
tion of a panel of experts in the construction of the ques-
tionnaire and the values obtained in Cronbach’s alpha 
gave us the necessary support in aspects related to the 
validity of appearance, content and construct to apply the 
questionnaire in our study.
A single-use disposable bronchoscope has significant 
advantages related to reducing the risk of cross infection, 
ease of compliance with cleaning and disinfection regu-
lations  during non-working hours, and reducing costs 
related to trauma repairs during use or reprocessing of 
the equipment. Studies on the effectiveness of repro-
cessing techniques have shown failures that can occur 
even when current regulations are followed [4, 5]. This 
makes single-use bronchoscopes preferable for patients 
at increased risk of infection, such as immunocompro-
mised patients, or those at risk of spreading infections by 
resistant or virulent germs (e.g., hepatitis B and C, HIV, 
multi-resistant bacteria and tuberculosis, among other). 
Particularly, during the current COVID-19 pandemic 
most respiratory societies have recommended disposable 
bronchoscopes to decrease transmission of the SARS-
CoV-2 to other patients and to the health care provid-
ers [8–11]. However, these advantages would be of little 
value if the bronchoscope did not fulfill its functions with 
quality.
Given their high sensitivity to detect changes in posi-
tive or negative trends, the cumulative checksum graphs 
(CUSUM) are probably the most appropriate method 
to evaluate the introduction of new technologies, study 
learning curves and assess the quality of the results 
[15–17, 19]. This analysis showed that the aScope4 did 
not require a learning curve in aspects related to equip-
ment assembly and aspiration quality, probably because 
it works similarly to reusable bronchoscopes. The dis-
posable sheaths, also designed to reduce the risk of cross 
infection, had some difficulties in these aspects [20], the 
advantage of the single-use bronchoscope may be due to 
not needing to couple an external sheath with a second 
working channel. Image quality, ease of tracheal intuba-
tion and maneuvering had standardized scores ≥ 80/100 
from the 9th procedure, with previous scores between 
70/100 and 80/100, these results show a good perfor-
mance of the aScope4 from the first procedure and excel-
lent performance from the 9th procedure. However, like 
previous studies on the quality of single-use broncho-
scopes [14, 21, 22] or disposable sheaths [20]. They did 
not evaluate the existence of learning curves by methods 
validated for this purpose, nor did they use standardized 
questionnaires. Their comparison with our results has 
these limitations. In this study 54.4% of physicians found 
the quality of images worse than those from reusable 
videobronchoscopes. Thus, reusable videobronchoscopes 
remain the cornerstone in interventional pulmonology 
units.
In a study done with a previous version of aScope4, 
aScope2 [21], authors observed lower image quality and 
greater difficulty in maneuverability. In our study, the 
scores in the domains related to image quality, maneu-
verability, aspiration, ease of assembly and general satis-
faction were good, which is probably due to the technical 
improvements made in this new version of the device. 
Our study has as limitations not having included more 
complex procedures such as taking biopsies or punc-
tures and not having included a control group, so that it 
does not allow us to establish the usefulness of aScope 4 
for such procedures or the superiority or inferiority of 
aScope 4 versus other video bronchoscopes.
Among the advantages of the aScope 4 they highlighted 
the fact that it is sterile, that it is for single use, the port-
ability and immediacy to start the procedure, the pos-
sibility of taking and storing videos and photos of the 
procedure. Taking and storing images can be particu-
larly useful when the equipment is used in intensive care 
units, where fiberoptic bronchoscopes having such func-
tionality are often not used, and therefore the exploration 
is only visualized by the bronchoscopist who performs it. 
The aScope 4 indications are very varied, such as emer-
gency situations, COVID infections, mycobacteria or 
multi-resistant germs, immunosuppressed patients, ICU 
admissions, etc. This device also constitutes an advantage 
in the training of specialists because it allows them to vis-
ualize the examination or teach the bronchoscopic find-
ings to the members of the medical team and could also 
reduce the costs related to the damage of such equipment 
due to the trauma they receive when entering through 
orotracheal  tubes or non-invasive ventilation masks. In 
addition, the characteristics of the aScope 4 allow it to 
be kept permanently at the patient’s bedside when there 
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are serious problems with airway obstruction due to 
abundant secretions, so that they can be aspirated under 
direct vision in a way that is probably more effective than 
blindly. Finally, one of the factors to take into account in 
the future is the possible ecological impact of this device 
since it is necessary to dispose of it after use and because 
it is made of plastic materials.
Conclusions
The aScope 4 scored very well in terms of ease of use, 
image quality, and aspiration. We observed a learning 
curve with excellent scores from the 9th procedure. They 
highlighted its portability, immediacy of use and the pos-
sibility of taking and storing images.
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